百日咳疫苗市场报告：2030 年趋势、预测与竞争分析

百日咳疫苗趋势与预测

预计到 2030 年，全球百日咳疫苗市场将达到约 91 亿美元，2024 年至 2030 年复合年增长率为 5.6%。该市场的主要驱动因素是人们对百日咳疫苗接种重要性的认识不断提高、政府促进百日咳疫苗接种的支持措施以及新型百日咳疫苗的不断开发。由于疫苗接种中心、医院和诊所市场的商机，全球百日咳疫苗市场的未来性看好。

百日咳疫苗市场洞察

Lucintel 预计 Dtap 将继续占很大的市场份额，因为它作为预防白喉、破伤风和百日咳的组合疫苗具有重要用途。

由于老年人口的增加和百日咳死亡人数的增加，预计北美在预测期内将经历最高的增长。

市场规模/估计：以金额（B 美元）估计百日咳疫苗的市场规模。

趋势和预测分析：各个细分市场和地区的市场趋势（2018-2023）和预测（2024-2030）。

细分市场分析：按类型、最终用途和地区金额（十亿美元）估计百日咳疫苗市场规模。

区域分析：北美、欧洲、亚太地区和世界其他地区百日咳疫苗市场的区域细分。

成长机会：以百日咳疫苗类型、最终用途和地区进行成长机会分析。

策略分析：百日咳疫苗市场併购、新产品开发、竞争形势等。

基于波特五力模型的产业竞争实力分析。

本报告回答了 11 个关键问题：

• Q.1. 细分市场中最有前途和高成长的机会是什么？
• Q.2.哪个细分市场将以更快的速度成长？为什么？
• Q.3.您认为哪些地区未来会出现更快的成长？为什么？
• Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
• Q.5. 这个市场的商业风险和竞争威胁是什么？
• Q.6.这个市场有哪些新趋势？为什么？
• Q.7.市场客户需求有何改变？
• Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
• Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
• Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
• Q.11.过去五年发生了哪些併购事件，对产业产生了哪些影响？

目录

第一章执行摘要

第二章全球百日咳疫苗市场：市场动态

• 简介、背景、分类
• 供应链
• 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

• 宏观经济趋势（2018-2023）与预测（2024-2030）
• 全球百日咳疫苗市场趋势（2018-2023）与预测（2024-2030）
• 全球百日咳疫苗市场（按类型）
  • 百白破疫苗
  • 百日咳疫苗
• 全球百日咳疫苗市场（依最终用途）
  • 疫苗接种中心
  • 医院
  • 诊所
  • 其他的

第四章 2018-2030年区域市场趋势及预测分析

• 全球百日咳疫苗市场区域分布
• 北美百日咳疫苗市场
• 欧洲百日咳疫苗市场
• 亚太百日咳疫苗市场
• 其他地区百日咳疫苗市场

第五章竞争分析

• 产品系列分析
• 营运整合
• 波特五力分析

第六章 成长机会与策略分析

• 成长机会分析
  • 全球百日咳疫苗市场成长机会（按类型）
  • 全球百日咳疫苗市场成长机会（依最终用途）
  • 全球百日咳疫苗市场成长机会（按地区）
• 全球百日咳疫苗市场的新趋势
• 战略分析
  • 新产品开发
  • 扩大全球百日咳疫苗市场产能
  • 全球百日咳疫苗市场的合併、收购与合资企业
  • 认证和许可

第七章主要企业概况

• Protein Sciences
• GlaxoSmithKline
• Sanofi Pasteur
• Seqirus
• Merck Sharp & Dohme
• Novartis
• Astellas Pharma

Pertussis Vaccine Trends and Forecast

The future of the global pertussis vaccine market looks promising with opportunities in the vaccination center, hospital, and clinic markets. The global pertussis vaccine market is expected to reach an estimated $9.1 billion by 2030 with a CAGR of 5.6% from 2024 to 2030. The major drivers for this market are growing awareness of the importance of pertussis vaccination, supportive government initiatives to promote pertussis vaccination, and continous development of new pertussis vaccines.

A more than 150-page report is developed to help in your business decisions.

Pertussis Vaccine by Segment

The study includes a forecast for the global pertussis vaccine by type, end use, and region.

Pertussis Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Dtap Vaccine
• Tdap Vaccine

Pertussis Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Vaccination Centers
• Hospitals
• Clinics
• Others

Pertussis Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Pertussis Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies pertussis vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the pertussis vaccine companies profiled in this report include-

• Protein Sciences
• Glaxosmithkline
• Sanofi Pasteur
• Seqirus
• Merck Sharp & Dohme
• Novartis
• Astellas Pharma

Pertussis Vaccine Market Insights

Lucintel forecasts that Dtap will remain the larger segment due to its significant use as combinated vaccine that protects against diphtheria, tetanus, and pertussis.

North America is expected to witness highest growth over the forecast period due to increasing number of geriatric population and rising pertussis death cases in the region.

Features of the Global Pertussis Vaccine Market

Market Size Estimates: Pertussis vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Pertussis vaccine market size by type, end use, and region in terms of value ($B).

Regional Analysis: Pertussis vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, end uses, and regions for the pertussis vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the pertussis vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the pertussis vaccine market size?

Answer: The global pertussis vaccine market is expected to reach an estimated $9.1 billion by 2030.

Q.2 What is the growth forecast for pertussis vaccine market?

Answer: The global pertussis vaccine market is expected to grow with a CAGR of 5.6% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the pertussis vaccine market?

Answer: The major drivers for this market are growing awareness of the importance of pertussis vaccination, supportive government initiatives to promote pertussis vaccination, and continous development of new pertussis vaccines.

Q4. What are the major segments for pertussis vaccine market?

Answer: The future of the pertussis vaccine market looks promising with opportunities in the vaccination center, hospital, and clinic markets.

Q5. Who are the key pertussis vaccine market companies?

Answer: Some of the key pertussis vaccine companies are as follows:

• Protein Sciences
• Glaxosmithkline
• Sanofi Pasteur
• Seqirus
• Merck Sharp & Dohme
• Novartis
• Astellas Pharma

Q6. Which pertussis vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that Dtap will remain the larger segment due to its significant use as combinated vaccine that protects against diphtheria, tetanus, and pertussis.

Q7. In pertussis vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to increasing number of geriatric population and rising pertussis death cases in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the pertussis vaccine market by type (Dtap vaccine and Tdap vaccine), end use (vaccination centers, hospitals, clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Pertussis Vaccine Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Pertussis Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Pertussis Vaccine Market by Type
  • 3.3.1: Dtap Vaccine
  • 3.3.2: Tdap Vaccine
• 3.4: Global Pertussis Vaccine Market by End Use
  • 3.4.1: Vaccination Centers
  • 3.4.2: Hospitals
  • 3.4.3: clinics
  • 3.4.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Pertussis Vaccine Market by Region
• 4.2: North American Pertussis Vaccine Market
  • 4.2.2: North American Pertussis Vaccine Market by End Use: Vaccination Centers, Hospitals, clinics, and Others
• 4.3: European Pertussis Vaccine Market
  • 4.3.1: European Pertussis Vaccine Market by Type: Dtap Vaccine and Tdap Vaccine
  • 4.3.2: European Pertussis Vaccine Market by End Use: Vaccination Centers, Hospitals, clinics, and Others
• 4.4: APAC Pertussis Vaccine Market
  • 4.4.1: APAC Pertussis Vaccine Market by Type: Dtap Vaccine and Tdap Vaccine
  • 4.4.2: APAC Pertussis Vaccine Market by End Use: Vaccination Centers, Hospitals, clinics, and Others
• 4.5: ROW Pertussis Vaccine Market
  • 4.5.1: ROW Pertussis Vaccine Market by Type: Dtap Vaccine and Tdap Vaccine
  • 4.5.2: ROW Pertussis Vaccine Market by End Use: Vaccination Centers, Hospitals, clinics, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Pertussis Vaccine Market by Type
  • 6.1.2: Growth Opportunities for the Global Pertussis Vaccine Market by End Use
  • 6.1.3: Growth Opportunities for the Global Pertussis Vaccine Market by Region
• 6.2: Emerging Trends in the Global Pertussis Vaccine Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Pertussis Vaccine Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Pertussis Vaccine Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Protein Sciences
• 7.2: GlaxoSmithKline
• 7.3: Sanofi Pasteur
• 7.4: Seqirus
• 7.5: Merck Sharp & Dohme
• 7.6: Novartis
• 7.7: Astellas Pharma